EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention Article

sustainable development goals

publication date

  • April 1, 2016

webpage

published in

keywords

  • MTP-131
  • Mitochondrial dysfunction
  • PCI
  • Reperfusion injury
  • STEMI

start page

  • 1296

end page

  • 1303

volume

  • 37

issue

  • 16